Pia Ragno
Fisciano, 84084, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children.
Journal: Pharmaceutics
Published: October 16, 2023
Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer.
Journal: International journal of molecular sciences
Published: November 24, 2022
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.
Journal: Cancers
Published: February 11, 2022
The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Journal: International journal of molecular sciences
Published: March 16, 2021
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.
Journal: Frontiers in oncology
Published: February 02, 2021
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.
Journal: Cells
Published: July 22, 2020
TLR4 Response to LPS Is Reinforced by Urokinase Receptor.
Journal: Frontiers in immunology
Published: June 17, 2020
N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor.
Journal: Frontiers in immunology
Published: October 25, 2017
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.
Journal: Current pharmaceutical design
Published: April 13, 2017
Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.
Journal: Translational medicine @ UniSa
Published: November 30, 2016
Last Updated: 09/26/2026